ConductScience.org, home

Paper7520105

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

Lancet, 1994. Cited by 387 papers, by iCite.

Cite this record

ConductScience Library. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Papers, record 7520105. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7520105

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
PubMed
Journal
Lancet
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
387
iCite
Relative citation ratio, by iCite
14.3
iCite
Revised in PubMed
2022-03-31
PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclosporineMajor topic
Graft RejectionMajor topic
Immunosuppression TherapyMajor topic
Liver TransplantationMajor topic
TacrolimusMajor topic
Acute Disease
Adolescent
Adrenal Cortex Hormones
Adult
Aged
Chronic Disease
Female
Graft Survival
Humans
Incidence
Infections
Male
Middle Aged
Survival Rate

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04657562The New LC-MS/MS Method for Determination of Unbound Tacrolimus in PlasmaBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in7523805Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection.https://conductscience.org/library/papers/7523805PubMed
Comment in7523807Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection.https://conductscience.org/library/papers/7523807PubMed

Download CSV of comments and corrections

Cited by118

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 387 citations.

PMIDTitleJournalYearIn PapersSource
42840765Calcineurin inhibitor monitoring in allogeneic hematopoietic cell transplantation: time to move beyond solid organ transplant paradigms.Front Immunol2026https://conductscience.org/library/papers/42840765PubMed
42604426
Comparison in Patients' Adherence, Adverse Effects, and Clinical Outcomes Among Liver Transplant Recipients Using Immediate-Release Tacrolimus (Prograf®) Versus Extended-Release Tacrolimus (Advagraf®): First Report from Iran.
Arch Iran Med2026https://conductscience.org/library/papers/42604426PubMed
41312559Post-liver transplant mortality in Canada: A retrospective analysis and quality assurance study in British Columbia.Can Liver J2025https://conductscience.org/library/papers/41312559PubMed
40960492Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Developing During Tacrolimus Treatment: A Case Series.Muscle Nerve2025https://conductscience.org/library/papers/40960492PubMed
40142628Maintenance Immunosuppression in Kidney Transplantation: A Review of the Current Status and Future Directions.J Clin Med2025https://conductscience.org/library/papers/40142628PubMed
39898010Swallowed Topical Tacrolimus Induces Clinical and Histological Remission in a Subset of Patients with Severe Lymphocytic Esophagitis.Inflamm Intest Dis2025https://conductscience.org/library/papers/39898010PubMed
38774214Mechanism of tacrolimus in the treatment of lupus nephritis.Front Pharmacol2024https://conductscience.org/library/papers/38774214PubMed
38137854Tacrolimus Maintains the Balance of Neutrophil Extracellular Traps by Inducing DNA Methylation of Neutrophils to Reduce Immune Rejection.Life (Basel)2023https://conductscience.org/library/papers/38137854PubMed
37896130A Reversibly Thermoresponsive, Theranostic Nanoemulgel for Tacrolimus Delivery to Activated Macrophages: Formulation and In Vitro Validation.Pharmaceutics2023https://conductscience.org/library/papers/37896130PubMed
37675348Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications.Front Nephrol2023https://conductscience.org/library/papers/37675348PubMed
37614233Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance.Front Immunol2023https://conductscience.org/library/papers/37614233PubMed
37408814Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study.J Clin Transl Hepatol2023https://conductscience.org/library/papers/37408814PubMed
35967435Current status of xenotransplantation research and the strategies for preventing xenograft rejection.Front Immunol2022https://conductscience.org/library/papers/35967435PubMed
35707633Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy.Transpl Int2022https://conductscience.org/library/papers/35707633PubMed
34866097Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease.Intern Med2022https://conductscience.org/library/papers/34866097PubMed
34557582Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation.Transplant Direct2021https://conductscience.org/library/papers/34557582PubMed
32095514Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction.Transplant Direct2020https://conductscience.org/library/papers/32095514PubMed
31070990Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model.Hum Vaccin Immunother2020https://conductscience.org/library/papers/31070990PubMed
30487677Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants.J Clin Biochem Nutr2018https://conductscience.org/library/papers/30487677PubMed
29997983New frontiers in immunosuppression.J Thorac Dis2018https://conductscience.org/library/papers/29997983PubMed

See all 118 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7520105

GET https://conductscience.org/api/papers/v1/7520105/cited_by?page=2